DE60212153D1 - Tetrahydropyranderivate und ihre verwendung als therapeutika - Google Patents

Tetrahydropyranderivate und ihre verwendung als therapeutika

Info

Publication number
DE60212153D1
DE60212153D1 DE60212153T DE60212153T DE60212153D1 DE 60212153 D1 DE60212153 D1 DE 60212153D1 DE 60212153 T DE60212153 T DE 60212153T DE 60212153 T DE60212153 T DE 60212153T DE 60212153 D1 DE60212153 D1 DE 60212153D1
Authority
DE
Germany
Prior art keywords
sup
sub
replaced
hydrogen atoms
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60212153T
Other languages
English (en)
Other versions
DE60212153T2 (de
Inventor
Pineiro Jose Luis Castro
Duncan Edward Shaw
Brian John Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of DE60212153D1 publication Critical patent/DE60212153D1/de
Publication of DE60212153T2 publication Critical patent/DE60212153T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60212153T 2001-09-10 2002-09-06 Tetrahydropyranderivate und ihre verwendung als therapeutika Expired - Lifetime DE60212153T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0121874 2001-09-10
GBGB0121874.2A GB0121874D0 (en) 2001-09-10 2001-09-10 Therapeutic agents
PCT/GB2002/004085 WO2003022839A1 (en) 2001-09-10 2002-09-06 Tetrahydropyran derivatives and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
DE60212153D1 true DE60212153D1 (de) 2006-07-20
DE60212153T2 DE60212153T2 (de) 2007-05-24

Family

ID=9921835

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212153T Expired - Lifetime DE60212153T2 (de) 2001-09-10 2002-09-06 Tetrahydropyranderivate und ihre verwendung als therapeutika

Country Status (17)

Country Link
US (1) US7265110B2 (de)
EP (1) EP1427723B1 (de)
JP (1) JP2005506329A (de)
KR (1) KR20040045435A (de)
CN (1) CN1578778A (de)
AT (1) ATE328881T1 (de)
BR (1) BR0212454A (de)
CA (1) CA2459464A1 (de)
DE (1) DE60212153T2 (de)
ES (1) ES2263803T3 (de)
GB (1) GB0121874D0 (de)
IL (1) IL160785A0 (de)
MX (1) MXPA04002295A (de)
NO (1) NO20041431L (de)
PL (1) PL368208A1 (de)
RU (1) RU2004110950A (de)
WO (1) WO2003022839A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
JP2006519822A (ja) * 2003-03-07 2006-08-31 メルク シャープ エンド ドーム リミテッド タキキニン拮抗薬としてのテトラヒドロピラン化合物
US11773127B2 (en) * 2017-11-08 2023-10-03 Washington University Compounds and methods for treating bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0906315A1 (de) * 1996-06-21 1999-04-07 MERCK SHARP & DOHME LTD. Spiro-piperdin-derivate und ihre verwendung als therapeutica
CO5150225A1 (es) 1999-03-19 2002-04-29 Merck Sharp & Dohme Derivados del tetrahidropirano y su uso como agentes terapeuticos
GB0020721D0 (en) * 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
US20040254184A1 (en) 2004-12-16
EP1427723A1 (de) 2004-06-16
CA2459464A1 (en) 2003-03-20
WO2003022839A1 (en) 2003-03-20
EP1427723B1 (de) 2006-06-07
DE60212153T2 (de) 2007-05-24
GB0121874D0 (en) 2001-10-31
ATE328881T1 (de) 2006-06-15
NO20041431L (no) 2004-06-01
JP2005506329A (ja) 2005-03-03
PL368208A1 (en) 2005-03-21
BR0212454A (pt) 2004-10-19
IL160785A0 (en) 2004-08-31
RU2004110950A (ru) 2005-04-10
MXPA04002295A (es) 2004-06-18
KR20040045435A (ko) 2004-06-01
ES2263803T3 (es) 2006-12-16
CN1578778A (zh) 2005-02-09
US7265110B2 (en) 2007-09-04

Similar Documents

Publication Publication Date Title
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
HK1068136A1 (en) Muscarinic antagonists
SG159380A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
NO20083114L (no) Polysykliske indazolderivater som er ERK-inhibitorer
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
TW200621786A (en) Condensed pyrazole derivatives, their preparation and application in therapeutics
DK1765816T3 (da) Substituerede 1-propinylpiperaziner med affinitet for MGluR5-receptoren til behandling af smertetilstande
TW200731013A (en) Salt suitable for an acid generator and a chemically amplified resist composition containing the same
AR068813A1 (es) Derivados de pirazol sustituidos como antagonistas del receptor de androgenos (ar), un agente farmaceutico que los comprende y su uso en el tratamiento del cancer de prostata
MX2007013203A (es) Nuevas aminas ciclicas.
TW200745032A (en) Novel heterobicyclic derivatives
MX2009010823A (es) Compuesto de hidrazida y agente controlador de artropodos dañinos que contiene el mismo.
EA200500862A1 (ru) Синоменин и соединения синоменина, синтез и применение
MX2009003073A (es) Derivado de 2-piridincarboxamida que tiene efecto activador de gk.
UA88329C2 (en) Dna-pk inhibitors
UA96947C2 (ru) Производные циннамоил-пиперазина и их применение как антагонистов par-1
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE374773T1 (de) Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
DE60212153D1 (de) Tetrahydropyranderivate und ihre verwendung als therapeutika
WO2003103590A3 (en) HETEROBICYCLIC P38 (HALO-BENZO CARBONYL) KINASE INHIBITORS
TW200420292A (en) Benzofuran derivative
MX2010008448A (es) Compuesto de bencilpiperizina.
DE602004017141D1 (de) Tetrahydropyranverbindungen als tachykininantagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition